IP Library Granted Patent US 8,470,987
Granted Patent B2
US 8,470,987 · App. 12/882,390 · Granted Jun 25, 2013

Protective group for synthesis of RNA and derivative

Inventors: Takeshi Wada (Chiba, JP); Mamoru Shimizu (Chiba, JP)
Assignee: Chiralgen, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,987
App. No.
12/882,390
Granted
Jun 25, 2013
Kind
B2
Abstract

A protective group represented by the following general formula (I) (the oxygen atom attached with * represents oxygen atom of 2′-hydroxyl group of a ribonucleoside, a ribonucleotide or a derivative thereof; R 1 and R 2 both represent hydrogen atom, or represent a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; R 3 and R 4 represent hydrogen atom, a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; and R 5 and R 6 represent a halogen atom, a C 1-6 halo-substituted alkyl group, cyano group, nitro group, or the like), which is stable under the reaction conditions of the nucleic acid synthetic cycles and has little steric hindrance, and can be removed under mild conditions using fluoride ions as a base.

Claims (22)

1. A protective group for 2′-hydroxyl group of a ribonucleoside or ribonucleotide, which is represented by the following general formula (I):

wherein, the oxygen atom attached with * represents an oxygen atom of the 2′-hydroxyl group of a ribonucleoside or ribonucleotide; R 1 and R 2 both represent a hydrogen atom, or independently represent a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; R 3 and R 4 independently represent a hydrogen atom, a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; and R 5 and R 6 represent the same fluoro-substituted C 1-6 alkyl group or the same perfluoro(C 1-6 alkyl) group.

2. The protective group according to claim 1 , wherein both R 1 and R 2 are hydrogen atoms.

3. The protective group according to claim 1 , wherein both R 3 and R 4 are hydrogen atoms.

4. The protective group according to claim 1 , wherein R 5 and R 6 represent the same fluoro-substituted C 1-6 alkyl group.

5. The protective group according to claim 1 , wherein R 5 and R 6 represent the same perfluoro(C 1-6 alkyl) group.

6. The protective group according to claim 1 , wherein both R 5 and R 6 are trifluoromethyl groups.

7. The protective group according to claim 1 , wherein the ribonucleoside or ribonucleotide is a phosphoroamidite compound.

8. A ribonucleoside or a ribonucleotide, wherein the oxygen atom of the 2′-hydroxyl group is protected with the protective group according to claim 1 .

9. The ribonucleoside or ribonucleotide according to claim 8 , which is a phosphoroamidite compound.

10. The ribonucleoside or ribonucleotide according to claim 9 , wherein the phosphoroamidite compound is a compound represented by the following general formula (II):

wherein, B represents a natural or non-natural nucleobase which may have a protective group; R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 have the same meanings as those defined above; R 11 represents a trityl group which optionally has a substituent, or a trityl group in which two phenyl groups among the three phenyl groups constituting the trityl group bind to each other via an oxygen atom to form a xanthene ring; R 12 and R 13 independently represent a C 1-6 alkyl group, or R 12 and R 13 bind to each other to form a saturated 5- or 6-membered ring, the ring constituting atoms optionally containing one or two or more oxygen atoms or sulfur atoms; R 14 and R 15 independently represent a hydrogen atom or a C 1-6 alkyl group, provided that R 14 may bind to R 13 to form a 5- or 6-membered ring; R 16 represents an electron withdrawing group, or when R 14 binds to R 13 to form a 5- or 6-membered ring, R 16 represents an electron withdrawing group or a hydrogen atom; and R 17 and R 18 represent a hydrogen atom or a C 1-6 alkyl group, or R 16 , R 17 , and R 18 bind to one another to represent an aryl group together with the carbon atoms to which they bind.

11. The ribonucleoside or ribonucleotide according to claim 10 which is a compound represented by the following formula (IIA):

wherein the symbols have the same meanings as those defined above.

12. A method for preparing an oligoribonucleic acid, comprising reacting the phosphoroamidite compound according to claim 10 in a reaction for synthesizing the oligoribonucleic acid.

13. A method for introducing a protective group for a 2′-hydroxyl group of a ribonucleoside or ribonucleotide, which is represented by the following general formula (I):

wherein, the oxygen atom attached with * represents an oxygen atom of the 2′-hydroxyl group of a ribonucleoside or ribonucleotide; R 1 and R 2 both represent a hydrogen atom, or independently represent a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; R 3 and R 4 independently represent a hydrogen atom, a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; and R 5 and R 6 represent the same fluoro-substituted C 1-6 alkyl group or the same perfluoro(C 1-6 alkyl) group, wherein the method comprises reacting a reagent comprising a compound represented by the following general formula (III):

wherein, R 3 , R 4 , R 5 , and R 6 have the same meanings as those defined above, and R 21 represents a hydroxyl group, with a ribonucleoside or a ribonucleotide of which the 2′-hydroxyl group is protected with a C 1-6 alkylthiomethyl group.

14. A method for introducing the protective group for a 2′-hydroxyl group of a ribonucleoside or a ribonucleotide, which is represented by the following general formula (I):

wherein, the oxygen atom attached with * represents oxygen atom of 2′-hydroxyl group of a ribonucleoside, a ribonucleotide or a derivative thereof; R 1 and R 2 both represent hydrogen atom, or independently represent a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; R 3 and R 4 independently represent hydrogen atom, a halogen atom, a C 1-6 alkyl group, or a C 1-6 halo-substituted alkyl group; and R 5 and R 6 represent the same fluoro-substituted C 1-6 alkyl group or the same perfluoro(C 1-6 alkyl) group,

wherein the method comprises reacting a reagent comprising a compound represented by the following general formula (III):

wherein, R 3 , R 4 , R 5 , and R 6 have the same meanings as those defined above, R 21 represents R 22 —S—C(R 1 )(R 2 )—O—, wherein in the formula R 22 represents a C 1-6 alkyl group, and R 1 and R 2 have the same meanings as those defined above, or X—C(R 1 )(R 2 )—O—, wherein in the formula, X represents a leaving group, and R 1 and R 2 have the same meanings as those defined above, with a ribonucleoside or ribonucleotide of which the 2′-hydroxyl group is not protected.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2017
From: WAVE LIFE SCIENCES JAPAN, INC.
To: WAVE LIFE SCIENCES LTD.
Reel/Frame 044199/0440 →
CHANGE OF NAME Recorded Aug 3, 2015
From: CHIRALGEN, LTD.
To: WAVE LIFE SCIENCES JAPAN
Reel/Frame 036236/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2011
From: WADA, TAKESHI; SHIMIZU, MAMORU
To: CHIRALGEN, LTD.
Reel/Frame 026076/0067 →
Continuity (2)
Provisional Application 61242877 · Sep 16, 2009
Related Publication 20110178284A1 · Jul 21, 2011